Modus Therapeutics Holding AB (publ) (STO:MODTX)
Sweden
· Delayed Price · Currency is SEK 0.289
-0.009 (-3.11%)
Mar 9, 2026, 5:24 PM CET
STO:MODTX Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 11.37 | 4.38 | 19.06 | 10.42 | 20.65 | Upgrade
|
| Cash & Short-Term Investments | 11.37 | 4.38 | 19.06 | 10.42 | 20.65 | Upgrade
|
| Cash Growth | 159.72% | -77.03% | 82.85% | -49.52% | 181.12% | Upgrade
|
| Other Receivables | 1.31 | 0.19 | 0.67 | 0.23 | 0.25 | Upgrade
|
| Receivables | 1.31 | 0.19 | 0.67 | 0.23 | 0.25 | Upgrade
|
| Prepaid Expenses | - | 0.26 | 0.26 | 0.57 | 0.24 | Upgrade
|
| Total Current Assets | 12.69 | 4.83 | 19.99 | 11.22 | 21.14 | Upgrade
|
| Other Long-Term Assets | - | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Total Assets | 12.69 | 4.88 | 20.04 | 11.27 | 21.19 | Upgrade
|
| Accounts Payable | 2.27 | 1.56 | 1.31 | 1.36 | 4.49 | Upgrade
|
| Accrued Expenses | 1.17 | 0.96 | 0.53 | 0.86 | 0.83 | Upgrade
|
| Short-Term Debt | - | - | - | 11.5 | - | Upgrade
|
| Current Income Taxes Payable | - | - | - | 0.04 | - | Upgrade
|
| Other Current Liabilities | 0.18 | 0.23 | 0.52 | 0.1 | 0.14 | Upgrade
|
| Total Current Liabilities | 3.62 | 2.75 | 2.36 | 13.86 | 5.46 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | -0 | Upgrade
|
| Total Liabilities | 3.62 | 2.75 | 2.36 | 13.86 | 5.46 | Upgrade
|
| Common Stock | 7.3 | 2.16 | 2.16 | 0.97 | 0.97 | Upgrade
|
| Additional Paid-In Capital | 353.24 | 332.9 | 332.9 | 295.93 | 295.93 | Upgrade
|
| Retained Earnings | -351.46 | -332.92 | -317.37 | -299.48 | -281.16 | Upgrade
|
| Comprehensive Income & Other | - | 0 | - | - | 0 | Upgrade
|
| Shareholders' Equity | 9.07 | 2.14 | 17.68 | -2.59 | 15.74 | Upgrade
|
| Total Liabilities & Equity | 12.69 | 4.88 | 20.04 | 11.27 | 21.19 | Upgrade
|
| Total Debt | - | - | - | 11.5 | - | Upgrade
|
| Net Cash (Debt) | 11.37 | 4.38 | 19.06 | -1.08 | 20.65 | Upgrade
|
| Net Cash Growth | 159.72% | -77.03% | - | - | 181.12% | Upgrade
|
| Net Cash Per Share | 0.18 | 0.12 | 1.07 | -0.07 | 1.67 | Upgrade
|
| Filing Date Shares Outstanding | 121.63 | 35.94 | 35.94 | 16.1 | 16.1 | Upgrade
|
| Total Common Shares Outstanding | 121.63 | 35.94 | 35.94 | 16.1 | 16.1 | Upgrade
|
| Working Capital | 9.07 | 2.09 | 17.63 | -2.64 | 15.68 | Upgrade
|
| Book Value Per Share | 0.07 | 0.06 | 0.49 | -0.16 | 0.98 | Upgrade
|
| Tangible Book Value | 9.07 | 2.14 | 17.68 | -2.59 | 15.74 | Upgrade
|
| Tangible Book Value Per Share | 0.07 | 0.06 | 0.49 | -0.16 | 0.98 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.